This article on Cornell Medical College's work to develop quantum dots (luminescent nano-sized particles) that work as reporting markers to light up cancer cells suggests that some very promising advances in cancer diagnosis are just ahead.  The technology used to precisely control the conductive properties of these nanomaterials will need to rely on international standard measurements to enable the user to evaluate the performance of different materials using apples-to-apples comparisons.

One such standard now in development is one for determining the quantum efficiency of luminsecent nanoparticles like quantum dots.  Stakeholder groups such as the FDA and medical diagnostic equipment manufacturers are encouraged to get involved in this development work through the US Technical Advisory Group to IEC TC 113 to ensure their views are heard.


Leave a Reply

Your email address will not be published. Required fields are marked *

*


− 4 = three

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>